Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

FDA issues recall of Philips interventional imaging system due to safety risks
A communication error within the system can reportedly cause loss of imaging functionality mid-procedure.
FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging
The new F-18 flurpiridaz radiotracer is expected to help drive cardiac PET growth, but it requires waiting between rest and stress scans. Software from MultiFunctional Imaging can help care teams combat that problem.
A new payer tactic: Using AI to curtail routine radiology claims, after imaging is already delivered
“Unlike [prior authorization], this model does not delay patient care and does not hold members liable to pay for unneeded exams,” writes radiologist Mark Hiatt, MD, MBA.
'Promising' new PET agent for brain metastases put on FDA's Fast Track
Clinical trial results thus far have been promising, representing a significant step forward for the hundreds of thousands of patients affected by brain metastases.
Cardiac imaging pioneer remembered for his joy and enthusiasm
Former American Society of Echocardiography president and well-known cardiac ultrasound pioneer Roberto Lang, MD, died at the age of 73. He helped develop 3D echo technology that is now used by care teams on a daily basis.

AAIC 2014 convenes in Copenhagen

The Alzheimer's Association International Conference is schedule to be held July 12-17 at the Bella Center in Copenhagen, Denmark. The meeting will feature many scientific sessions, plenary sessions and symposia dedicated to the most up-to-date Alzheimer's disease research.

Data uncover genomic signatures of most common lung cancer

Specific genetic mutations in an ear-marked pathway now have been implicated in the development of lung adenocarcinoma, the most prevalent subtype of lung cancer, according to a study published online July 9 in Nature. The discovery of these mutations could hone drug targets for new therapies down the road.

Patients at Henry Ford Wyandotte now receive half-dose nuclear medicine imaging

UltraSpect, provider of the only multi-vendor and most cost-effective imaging solution for meeting the American Society of Nuclear Cardiology (ASNC) low dose guidelines, announces today that Henry Ford Wyandotte Hospital in Michigan has upgraded its nuclear medicine (NM) image reconstruction software to UltraSpect Xpress3.Cardiac. As a result, all patients receiving NM exams now have exams in half the time, with half the dose, regardless of the model or age of camera being used.

AAA financials reveal 30% uptick in sales

An annual financial report from Advanced Accelerator Applications (AAA) in Saint-Genis-Pouilly, France, announced yesterday that the company’s sales were up just over 30 percent to almost $80 million.

Protea and InSphero collaborate on 3D preclinical imaging

Protea Biosciences based in West Virginia and Swiss biotech firm InSphero announced this week that the companies are combining their 3D technologies into one preclinical imaging platform.

Vizamyl amyloid PET agent moves one step closer to CE mark

The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) has given an encouraging nod toward final approval for European marketing of the amyloid-aiming PET agent F-18 flutemetamol (Vizamyl).

Oligomerix’s anti-tau therapy prospectus to be presented this month

Alzheimer’s therapeutics company Oligomerix announced June 30 that Oligomerix representatives will be presenting the company’s drug development program during poster and scientific sessions at the upcoming Federation of European Neuroscience Societies (FENS) Forum of Neuroscience and the Alzheimer's Association International Conference (AAIC).

Global companion diagnostics market reached $26B last year and growing

The market for companion diagnostics was valued at $26 billion in 2013 and is projected to grow at an annual growth rate of 22.9 percent during the next decade, according to a new market research report published in June and announced by Research and Markets.

Medical Imaging

FDA issues recall of Philips interventional imaging system due to safety risks

FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging

A new payer tactic: Using AI to curtail routine radiology claims, after imaging is already delivered

'Promising' new PET agent for brain metastases put on FDA's Fast Track

Cardiac imaging pioneer remembered for his joy and enthusiasm